InvestorsHub Logo
Post# of 251305
Next 10
Followers 49
Posts 644
Boards Moderated 0
Alias Born 05/02/2011

Re: DewDiligence post# 191767

Wednesday, 05/27/2015 9:16:48 PM

Wednesday, May 27, 2015 9:16:48 PM

Post# of 251305
Viberzi (eluxadoline)

"We are very pleased to be working with the FDA to advance this IBS-D treatment and we eagerly await DEA scheduling determination later this year." My bolding.

http://www.prnewswire.com/news-releases/actavis-receives-fda-approval-for-viberzi-eluxadoline-for-the-treatment-of-irritable-bowel-syndrome-with-diarrhea-ibs-d-in-adults-300089793.html

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.